- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 46.85M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 46.92M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 25.95M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$142.61K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$22.66K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $216.37K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $358.98K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$2.87M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$3.38M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$5.08M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$5.07M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.13M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.77M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.13M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.77M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $259.66K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $397.51K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $259.66K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $397.51K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $5.98K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $4.26K |
| Net Income | Q1 2026 · Mar 31, 2026 | $177.8K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.41K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$488.09K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$78.84K |
| Revenue | Q1 2026 · Mar 31, 2026 | $32.67K |